Literature DB >> 11395286

Neurosurgical treatment of medically intractable status epilepticus.

X Ma1, J Liporace, M J O'Connor, M R Sperling.   

Abstract

Medically intractable status epilepticus can be defined as status epilepticus (SE) that persists or recurs despite medical treatment with intravenous agents that suppress cortical activity. We describe the successful neurosurgical treatment of three patients with medically intractable status epilepticus who responded either to focal resection, multiple subpial transection, or callosal section. The duration of medically intractable status epilepticus before surgery ranged between 23 and 42 days, and multiple medical complications occurred during the failed medical therapy. We suggest that patients with medically intractable status epilepticus who fail to respond to three courses of cerebral suppressant therapy for approximately 2 weeks be considered for surgical treatment in the absence of any known remitting etiology. Focal resection and/or subpial transection is preferred for intractable partial SE with focal electrographic changes or a focal lesion demonstrated by structural or functional neuroimaging. Corpus callosotomy may be used for patients with generalized or non-localizable intractable status epilepticus.

Entities:  

Mesh:

Year:  2001        PMID: 11395286     DOI: 10.1016/s0920-1211(01)00252-2

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  25 in total

1.  Multiple Subpial Transections for Medically Refractory Epilepsy: A Disaggregated Review of Patient-Level Data.

Authors:  John D Rolston; Hansen Deng; Doris D Wang; Dario J Englot; Edward F Chang
Journal:  Neurosurgery       Date:  2018-05-01       Impact factor: 4.654

Review 2.  Treatment of Super-Refractory Status Epilepticus.

Authors:  Ahmad Bayrlee; Nimalya Ganeshalingam; Lisa Kurczewski; Gretchen M Brophy
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

3.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 4.  Anterior Temporal Lobectomy for Refractory Status Epilepticus in Herpes Simplex Encephalitis.

Authors:  Sarah K B Bick; Saef Izzy; Daniel B Rubin; Sahar F Zafar; Eric S Rosenthal; Emad N Eskandar
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

5.  Status Epilepticus.

Authors:  Elizabeth J. Waterhouse
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

Review 6.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 8.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

Review 9.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

10.  The role of neurosurgery in status epilepticus.

Authors:  Yu-Tze Ng; Ruth E Bristol; Dewi V Schrader; Kris A Smith
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.